On August 27, 2018 Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of curative therapeutics using CRISPR/Cas9 technology, reported that it will participate in the following upcoming healthcare conferences in September (Press release, Intellia Therapeutics, AUG 27, 2018, View Source [SID1234529472]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Tuesday, September 4, 2018
B. Riley FBR Healthcare Conference
Panel: A Beginner’s Guide to Gene Therapy
Location: New York, NY
Time: 12:50pm ET
Wednesday, September 5, 2018
Citi Biotech Conference
Panel: Gene Editing
Location: Boston, Massachusetts
Time: 1:15pm ET
Thursday, September 6, 2018
Wells Fargo Healthcare Conference
Location: Boston, Massachusetts
Time: 3:05pm ET
Thursday, September 27, 2018
Jefferies Gene Therapy Summit
Location: New York, NY
A live webcast of Intellia’s participation on the panel at the Citi Biotech Conference and presentation at the Wells Fargo Healthcare Conference will be accessible through the Events and Presentations page of the Investor Relations section of the company’s website at www.intelliatx.com. To access the webcasts, please log on to the Intellia website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcasts will be available on Intellia’s website for approximately 14 days following each conference.